Cargando…
The SPARK Study: a phase II randomized blinded controlled trial of the effect of furosemide in critically ill patients with early acute kidney injury
BACKGROUND: Furosemide is commonly prescribed in critically ill patients with acute kidney injury (AKI). Existing data from observational studies and small clinical trials have significant limitations and have reported conflicting findings. There remains controversy on whether furosemide can impact...
Autores principales: | Bagshaw, Sean M, Gibney, RT Noel, McAlister, Finlay A, Bellomo, Rinaldo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874544/ https://www.ncbi.nlm.nih.gov/pubmed/20459801 http://dx.doi.org/10.1186/1745-6215-11-50 |
Ejemplares similares
-
Quality indicators in continuous renal replacement therapy (CRRT) care in critically ill patients: protocol for a systematic review
por: Rewa, Oleksa, et al.
Publicado: (2015) -
A proposed algorithm for initiation of renal replacement therapy in adult critically ill patients
por: Bagshaw, Sean M, et al.
Publicado: (2009) -
Furosemide is associated with acute kidney injury in critically ill patients
por: Levi, T.M., et al.
Publicado: (2012) -
Economics of dialysis dependence following renal replacement therapy for critically ill acute kidney injury patients
por: Ethgen, Olivier, et al.
Publicado: (2015) -
Trial of Furosemide to Prevent Acute Kidney Injury in Critically Ill Children: A Double-Blind, Randomized, Controlled Trial
por: Abraham, Shilpa, et al.
Publicado: (2021)